Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07223164 · ClinicalTrials.gov registry record · NA

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

A NA study of Healthy, sponsored by Masimo Corporation.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT07223164 is a NA study of Healthy that is actively recruiting participants, run by Masimo Corporation. The registered enrollment target is 120 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07223164, a NA study of Healthy, is actively recruiting participants, sponsored by Masimo Corporation.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Specificity measure of performance of the Irregular Heartbeat Detection algorithm (evaluated for the finger and wrist form factors) against the Masimo Radius VSM® reference ECG. Each form factor will be evaluated independently of one another

Conditions Studied

Interventions

  • DEVICE Masimo SET® and Masimo W1®

Study Locations (1)

California

  • Masimo Corporation - Irvine

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-10-21
Est. Completion 2026-06-01
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT07223164

The ClinicalTrials.gov registry entry for NCT07223164 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Masimo SET® and Masimo W1® is the first listed.

NCT07223164 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07223164 about?

NCT07223164 is a clinical study titled "Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease". Specificity measure of performance of the Irregular Heartbeat Detection algorithm (evaluated for the finger and wrist form factors) against the Masimo Radius VSM® reference ECG. Each form factor will be evaluated independently of one another

What is the current status of trial NCT07223164?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-10-21. Estimated completion is 2026-06-01.

What conditions does trial NCT07223164 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT07223164?

The interventions under investigation include: Masimo SET® and Masimo W1® (DEVICE).

Who is sponsoring clinical trial NCT07223164?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07223164 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.